Hunter Clot Clinic Referrals
For patient’s with new PE/DVT, especially those with unprovoked VTE disease.
COBRRA Trial
Study Title: COmparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism.
Patients excluded from trial should still be referred on the the Clot Clinic if they are being discharged home from ED with a new Acute Thrombus